. Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients - IOPAC Press "Enter" to skip to content

WHO adds LC16m8 mpox vaccine to Emergency Use Listing
- All WHO news
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second...
WHO Investment Round: culminating moment at G20 Summit as leaders pledge
- All WHO news
The first-ever Investment Round of the World Health Organization (WHO) reached a culminating moment during the G20 Leaders' Summit today in...
WHO and partners rally cervical cancer elimination efforts
- All WHO news
As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city’s iconic Christ the...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients

By iopac on November 21, 2024

The greatest risk reductions in COVID-related and all-cause deaths were seen among women and hospitalized patients.

Published in COVID-19

iopac